Overview


According to FutureWise analysis the market for malaria diagnostics in 2023 is US$ 0.82 billion, and is expected to reach US$ 1.2 billion by 2031 at a CAGR of 4.95%.

Malaria diagnostics refers to the process of detecting the presence of the malaria parasite or its antigens in a patient's blood, tissue, or other bodily fluids. The Plasmodium parasite is the primary cause of the deadly and even fatal illness malaria, which infects mosquitoes and is spread to people through their bites. Accurate and timely diagnosis of malaria is crucial for effective therapy and management of the disease. Malaria diagnostics involve various methods, including microscopic examination of blood smears, rapid diagnostic tests (RDTs), molecular diagnostic techniques, and serological assays.

Microscopic examination of blood smears is the traditional method of diagnosing malaria, where a trained laboratory technician examines a sample of the patient's blood under a microscope to look for the malaria parasite's existence. Rapid diagnostic tests (RDTs) have become increasingly popular in recent years due to their speed, simplicity, and affordability. RDTs use a small amount of blood to detect the presence of malaria antigens, providing results within 15-20 minutes. They are widely used in resource-limited settings, such as rural areas or areas with restricted access to laboratory services. Molecular diagnostic techniques, such as PCR tests, are highly sensitive and specific, providing accurate and reliable results. These techniques can detect low levels of the malaria parasite in the blood and can distinguish between different species of Plasmodium, which is important for selecting the appropriate treatment.

FutureWise Market Research has published a report that provides an insightful analysis of Malaria Diagnostics Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Malaria Diagnostics Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Abbott Laboratories
  • Access Bio. Inc.
  • Atlas Medical
  • Biomérieux SA
  • Bio-Rad Laboratories
  • Meridian Bioscience Inc
  • Novartis AG
  • Olympus Corporation
  • Premier Medical Corporation Pvt Ltd
  • Siemens AG
  • Beckman Coulter/Danaher
  • Life Technology
  • Ortho-Clinical Diagnostics
  • Wako Chemicals, Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Malaria Diagnostics Market:

  • In February 2022, The Plasmochek detection tool against malaria was introduced by the Kenya Medical Research Institute.
  • In June 2022, In order to eliminate malaria, SC Johnson and the Global Fund collaborated. The Global Fund has so far spent more than USD 16 billion on malaria control initiatives, accounting for 56% of all foreign funding for such programs.

The malaria diagnostics industry has grown significantly in recent years due to various factors, including the high prevalence of malaria in many regions of the world, technological advancements in diagnostic tests, and the increasing demand for accurate and rapid diagnostic tools. One of the primary forces of growth in the malaria diagnostics market is the high prevalence of malaria in numerous regions of the world, particularly in sub-Saharan Africa, where over 90% of malaria deaths occur. This has created a significant need for reliable and efficient diagnostic tools that can accurately detect malaria and differentiate it from other febrile illnesses. Technological advancements in diagnostic tests have also played an essential role in the expansion of the malaria diagnostics market. New diagnostic tools, such as rapid diagnostic tests (RDTs), polymerase chain reaction (PCR) tests, and loop-mediated isothermal amplification (LAMP) tests, have made it possible to diagnose malaria more accurately and quickly than ever before. In addition, there has been an expanding need for accurate and rapid diagnostic tools for malaria due to the advent of drug-resistant strains of the malaria parasite. Early and precise detection is vital for effective treatment and to prevent drug-resistant strains from spreading.

However, the malaria diagnostics market is not without its challenges. One of the most prevalent issues is the availability and accessibility of diagnostic tools in resource-limited settings, particularly in rural areas where malaria is most prevalent. The hefty price of diagnostic tests and the need for specialized equipment and trained personnel can make it difficult for healthcare providers in these areas to diagnose and treat malaria effectively.

By Technique

  • Rapid diagnostic tests
  • Microscopy
  • Molecular diagnostic tests
    • Conventional PCR
    • Real-Time PCR (qPCR)

By End User

  • Hospital
  • Clinic
  • Diagnostic Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The malaria diagnostics market is predominantly concentrated in the Middle East and Africa region, where malaria is most prevalent and where the burden of the disease is highest. The region accounts for over 90% of global malaria cases and deaths, and as a result, there is an essential demand for trustworthy and accurate diagnostic tools to aid in the detection and treatment of the disease. Countries in sub-Saharan Africa have been implementing various malaria control strategies, including the use of diagnostic tools, to reduce the burden of the disease. Rapid diagnostic tests have become the most commonly used diagnostic tool in the region due to their ease of use, speed, and affordability. In addition to RDTs, molecular diagnostic techniques, such as PCR tests, are also becoming increasingly used in the sub-Saharan African region for the diagnosis of malaria. These techniques provide higher sensitivity and specificity than RDTs, but they require more specialized equipment and training and are typically more expensive.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Malaria Diagnostics Market By Technique, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Malaria Diagnostics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Drug Class Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Malaria Diagnostics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Malaria Diagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Drug Class Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Drug Class Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Malaria Diagnostics Market, By Technique Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Rapid diagnostic tests
        2. Microscopy
        3. Molecular diagnostic tests
         3.1.Conventional PCR
         3.2.Real-Time PCR (qPCR)

  • 8.   Global Malaria Diagnostics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Clinic
        3. Diagnostic Centers

  • 9.   North America Malaria Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Malaria Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Malaria Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Malaria Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Access Bio. Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Atlas Medical
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Biomérieux SA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-Rad Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Meridian Bioscience Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Novartis AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Olympus Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Premier Medical Corporation Pvt Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Siemens AG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Beckman Coulter/Danaher
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Life Technology
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Ortho-Clinical Diagnostics
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Wako Chemicals, Inc
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients